Posted at 01:03h
in
News
by KMFSLLP
A California state agency announced its
intention to reject buy-now-pay-later company Sezzle Inc's
application for a lending license in the state, sending
its shares to a record low on Thursday.
...
Posted at 00:01h
in
News
by KMFSLLP
Social media appeal hopes to attract millennials as troop numbers fall
...
Posted at 23:00h
in
News
by KMFSLLP
Australian home prices ended 2019
with the biggest quarterly rise in a decade, a remarkable return
to boom from bust that promises to support consumer wealth and,
perhaps, spending.
...
Posted at 21:24h
in
News
by KMFSLLP
Australian shares are set to tumble at the
open on Thursday, as energy stocks, hit by weaker oil prices,
are likely to drag on the year's first trading session.
The local share price index futures ...
Posted at 20:00h
in
News
by KMFSLLP
Brexit worries will continue to curb investment according to FT’s annual survey
...
Posted at 20:00h
in
News
by KMFSLLP
Post-Brexit trade links with the EU and productivity remain big problems
...
Posted at 20:00h
in
News
by KMFSLLP
Post-Brexit trade links with the EU and productivity remain big problems
...
Posted at 19:04h
in
News
by KMFSLLP
* Escape plan evolved over three months-sources close to
Ghosn
...
Posted at 18:01h
in
News
by KMFSLLP
Algorithm reduces both false positives and false negatives
...
Posted at 16:09h
in
News
by KMFSLLP
Drugmakers including
Bristol-Myers Squibb Co, Gilead Sciences Inc,
and Biogen Inc hiked U.S. list prices on more than 50
drugs on Wednesday, bringing total New Year's Day drug price
increases to more than 250, according to data analyzed by
healthcare research firm 3 Axis Advisors.